Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Moodys
Dow
Baxter
Johnson and Johnson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SILODOSIN

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

SILODOSIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Allergan, Inc. 0023-6142-30 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Allergan, Inc. 0023-6142-90 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-90)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Allergan, Inc. 0023-6147-30 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6147-30)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Actavis Pharma, Inc. 52544-151-19 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-151-19)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Actavis Pharma, Inc. 52544-151-30 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-151-30)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Actavis Pharma, Inc. 52544-152-19 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-152-19)
Allergan RAPAFLO silodosin CAPSULE;ORAL 022206 NDA Actavis Pharma, Inc. 52544-152-30 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-152-30)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Moodys
Merck
Medtronic